Literature DB >> 21059341

Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion.

Nami Miyanishi1, Yukino Suzuki, Siro Simizu, Yoshiko Kuwabara, Kouji Banno, Kazuo Umezawa.   

Abstract

Ovarian carcinomas are often highly invasive, especially in the peritoneal cavity; however, the mechanism involved in invasion is not yet fully understood. In the present research, we studied the role of NF-κB in the invasiveness of ovarian carcinoma cells by using (-)-DHMEQ, a specific inhibitor of NF-κB. (-)-DHMEQ inhibited invasion in vitro and the expression of CXCL12 and CXCR4. We found that neutralizing antibody against CXCR4 or knockdown of CXCR4 suppressed the invasion. Proteomic analysis revealed that CXCR4-siRNA treatment lowered the secretion of several invasion-related proteins, such as MMP-9 and uPA. These data imply that (-)-DHMEQ suppressed ovarian cell invasion via inhibition of the NF-κB-regulated autocrine system of CXCL12-CXCR4.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059341     DOI: 10.1016/j.bbrc.2010.11.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia.

Authors:  Christina Arieta Kuksin; Gabriela Gonzalez-Perez; Lisa M Minter
Journal:  Blood       Date:  2015-02-03       Impact factor: 22.113

Review 2.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

3.  Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.

Authors:  Paramita Ray; Sarah A Lewin; Laura Anne Mihalko; Bradley T Schmidt; Kathryn E Luker; Gary D Luker
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

4.  DHMEQ enhances the cytotoxic effect of cisplatin and carboplatin in ovarian cancer cell lines.

Authors:  Marcin Michalak; Michał S Lach; Sylwia Borska; Błażej Nowakowski; Kazuo Umezawa; Wiktoria M Suchorska
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

5.  Stromal Cell-Derived Factor-1a Autocrine/Paracrine Signaling Contributes to Spatiotemporal Gradients in the Brain.

Authors:  Kassondra N Hickey; Shannon M Grassi; Michael R Caplan; Sarah E Stabenfeldt
Journal:  Cell Mol Bioeng       Date:  2020-08-07       Impact factor: 2.321

6.  The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

Authors:  A Popple; L G Durrant; I Spendlove; P Rolland; I V Scott; S Deen; J M Ramage
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

7.  Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.

Authors:  Xiu-Jie Sheng; Ying-Qun Zhou; Qing-Yuan Song; Dong-Mei Zhou; Qi-Cai Liu
Journal:  Oncol Rep       Date:  2011-12-19       Impact factor: 3.906

8.  The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis.

Authors:  Chee Wai Wong; Danielle E Dye; Deirdre R Coombe
Journal:  Int J Cell Biol       Date:  2012-01-09

Review 9.  A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.

Authors:  Changyuan Zhang; Jie Li; Yi Han; Jian Jiang
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162

Review 10.  Chemokine receptors in epithelial ovarian cancer.

Authors:  Goda G Muralidhar; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2013-12-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.